56
Participants
Start Date
February 1, 2024
Primary Completion Date
July 20, 2024
Study Completion Date
August 1, 2024
Dexmedetomidine
Dexmedetomidine (DEX), an α2-agonist with more promising pharmacokinetic and pharmacodynamic characteristics than clonidine has been proved to have a positive effect on postoperative pain intensity and to reduce opioid consumption
Bupivacaine Hydrochloride
local anesthesic which works through blocking sodium channels
Faculty of Medicine-Cairo Univeristy, Cairo
Cairo University
OTHER